Highest Dividend Paying Stock In April: Rs 117 Payout Incoming; Bulls Charge Ahead By Record Date 25th April?

A major multinational pharmaceutical firm in India, Sanofi India Limited is a subsidiary of the international healthcare conglomerate Sanofi. It has been operating in India since 1956 and provides a broad range of drugs and vaccines for different therapeutic areas. Sanofi India has production plants in Goa and Ankleshwar, Gujarat. Vaccines like Adacel, Avaxim, FluQuadri, and Hexaxim are among the well-known brands, along with Lantus, Combiflam, Amaryl, and Allegra that the company manages. Sanofi India maintains a worldwide capabilities center in Hyderabad in addition to its headquarters in Mumbai, Maharashtra. With a market valuation of Rs 13,445.95 Cr, Sanofi India's shares closed Tuesday's trading session on the BSE 1.94% higher at Rs 5838.45 a share.

Sanofi India Dividend

A final dividend of Rs 117/-per equity share of face value of Rs 10 each was recommended by the Board at its meeting on February 27, 2025, for the fiscal year that ended on December 31, 2024. This recommendation is contingent to shareholder approval at the 69th Annual General Meeting.

"In the above context, payment of the Final Dividend will be made to those members whose names are on the Company's Register of Members on Friday, 25th April 2025 ("Record Date") and those whose names appear as Beneficial Owners as at the close of the business hours on Friday, 25th April 2025 as per the details to be furnished by the Depositories, viz. NSDL and CDSL, for this purpose," said Sanofi India in a stock exchange filing.

Sanofi India Financials

Sales at Sanofi India Ltd. (SIL) were Rs 514.9 crore, rising 9.7% YoY from Rs 469.2 crore during the same time last year. EBITDA grew 18.8% year over year, from Rs 99.6 crore in Q4FY24 to Rs 118.3 crore in Q4FY25. The company's net profit dropped 33.7% from Rs 137.7 crore in the year-ago quarter to Rs 91.3 crore in the recent one.

Sanofi India Share Price Target

"Sanofi India (CMP ₹5729) continues its strong uptrend, supported by consistent buying interest, with key support at ₹5600 and resistance near ₹5850-₹5900. A breakout above ₹5900 could trigger a rally towards ₹6100, making it favorable for investors seeking steady returns. However, a breach below ₹5600 could indicate temporary weakness," said Riyank Arora - Technical Analyst - Mehta Equities Limited.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.